Updated: January 7, 2026
How to Save Money on Methscopolamine in 2026: Coupons, Discounts, and Patient Assistance
Author
Peter Daggett

- What Does Methscopolamine Cost Without Insurance?
- MedFinder savings card
- Option 3: RxSaver and Other Discount Programs
- Option 4: Insurance Coverage
- Option 5: Mail-Order for 90-Day Savings
- Are There Manufacturer Savings Programs for Methscopolamine?
- Comparing Your Options Side by Side
- Don't Forget: Find It Before You Worry About the Price
Overview
Methscopolamine can cost $150+ without insurance. Learn how to use GoodRx, SingleCare, and other strategies to cut your cost in 2026.
If you take methscopolamine bromide and you're paying full price at the pharmacy, you may be paying far more than you need to. The retail price for a 30-day supply can be $150 to $185 or more depending on the pharmacy. But with the right discount program, you can bring that cost down by 70% or more. Here's what's available in 2026.
What Does Methscopolamine Cost Without Insurance?
Without insurance or a discount card, the average retail price of generic methscopolamine bromide tablets is approximately $150 to $185 for a 30-day supply (60 tablets of 2.5 mg taken before each meal and at bedtime). The exact price varies by pharmacy and location.
Because the brand-name Pamine has been discontinued, there is only a generic available — which is typically less expensive than a brand, but for a low-demand drug like methscopolamine, the generic can still carry a high price tag. The good news is that discount programs can dramatically reduce the out-of-pocket cost.
MedFinder savings card
Our free discount card with low prices at 65,000+ pharmacies nationwide. Search your medication, compare the cash price near you, and show the card at the counter to save up to 80%. It's a discount, not insurance, and savings vary by drug and pharmacy. Note: pharmacies can choose not to participate. You can use it whether you find your medication with MedFinder or not.
Option 3: RxSaver and Other Discount Programs
RxSaver (owned by RetailMeNot) offers similar savings on methscopolamine. Other options include Blink Health, NeedyMeds, and the Walmart $4/$10 generic drug list — though not all programs will have methscopolamine at the deepest discount. It's worth checking two or three programs to compare prices at your specific pharmacy.
Option 4: Insurance Coverage
Methscopolamine coverage varies significantly by insurance plan. Some commercial plans cover it as a Tier 2 or Tier 3 drug with a $10–$50 copay. However, some plans — including some Medicare Part D plans — do not cover methscopolamine at all, especially since it's considered an older drug that has largely been replaced in treatment guidelines.
Before filling at retail price, always check:
Whether your insurance covers methscopolamine (check your plan's formulary online or call member services).
What tier it falls on and whether prior authorization is required.
Whether your the free MedFinder savings card price is lower than your insurance copay — if so, use the discount card instead.
Option 5: Mail-Order for 90-Day Savings
If your insurance covers methscopolamine, using your plan's mail-order pharmacy for a 90-day supply often reduces the per-unit cost and may come with a lower copay than retail. Ask your plan's member services team whether methscopolamine is available through mail-order. You'll need a new prescription written for a 90-day quantity.
Are There Manufacturer Savings Programs for Methscopolamine?
Currently, there are no manufacturer-sponsored copay cards or patient assistance programs for methscopolamine. Because the brand name Pamine has been discontinued and the drug is manufactured generically by multiple companies, there is no single manufacturer offering a savings program. Discount cards like the free MedFinder savings card are currently your best tool for reducing cost.
Comparing Your Options Side by Side
Retail (no discount): $150–$185 per 30-day supply
the free MedFinder savings card coupon: As low as $45
the free MedFinder savings card card: As low as $48
Insurance (if covered): $0–$50 depending on tier and deductible status
Manufacturer savings program: None currently available
Don't Forget: Find It Before You Worry About the Price
Even the best coupon doesn't help if your pharmacy doesn't have the drug in stock. Because methscopolamine can be hard to find at chain pharmacies, use medfinder to identify which nearby pharmacies carry it before you apply your discount. For a full guide on locating it, see: How to Find Methscopolamine In Stock Near You.
Frequently Asked Questions
With a GoodRx coupon, methscopolamine can cost as little as $45 per 30-day fill — compared to a retail price of around $152 without any discount. GoodRx Gold and Companion plans may lower the price further. Prices vary by pharmacy, so compare options in the GoodRx app by entering your zip code.
Coverage varies. Some Medicare Part D plans cover methscopolamine as a Tier 2 or Tier 3 drug with a copay, while others do not include it on their formulary at all. Check your specific plan's formulary at Medicare.gov or call your plan's member services line. If Medicare doesn't cover it, you can use a GoodRx or SingleCare coupon instead — these cannot be combined with insurance but can substitute for it.
No manufacturer-sponsored patient assistance program (PAP) currently exists for methscopolamine, because the brand-name Pamine has been discontinued and the drug is now produced generically. The best savings options are prescription discount cards like GoodRx and SingleCare, which can reduce the cost by up to 70%.
No. GoodRx and insurance cannot be used together at the same time for the same prescription. You must choose one or the other at the pharmacy. If your GoodRx price ($45) is lower than your insurance copay, it's worth using GoodRx. Your pharmacist can run both prices and tell you which is lower.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standards




